Malignant neoplasm of unspecified round ligament
ICD-10 C57.20 is a billable code used to indicate a diagnosis of malignant neoplasm of unspecified round ligament.
C57.20 refers to a malignant neoplasm located in the round ligament, which is a fibrous cord that extends from the uterus to the labia majora. This neoplasm is classified as malignant, indicating that it is cancerous and has the potential to invade surrounding tissues and metastasize to other parts of the body. The round ligament is not a common site for malignancies, making this diagnosis relatively rare. In gynecologic oncology, the presence of a malignant neoplasm in the round ligament may be associated with other gynecological cancers, such as ovarian or uterine cancer. Staging of this neoplasm is crucial for determining the extent of disease and guiding treatment options. The CA-125 blood test may be utilized as a tumor marker in the evaluation of gynecologic malignancies, although its specificity for round ligament tumors is limited. Surgical approaches may include excision of the tumor, and in some cases, a more extensive surgical procedure may be necessary depending on the tumor's size and involvement with adjacent structures. Accurate coding for C57.20 requires careful documentation of the diagnosis, staging, and any associated procedures performed.
Detailed pathology reports, imaging studies, and surgical notes are essential for accurate coding.
Diagnosis of a malignant neoplasm during routine gynecological exams or imaging studies.
Ensure that all relevant staging information and treatment plans are documented to support the coding.
Comprehensive pathology reports that specify tumor type, grade, and staging.
Pathological evaluation of excised tumors from the round ligament.
Pathology reports must clearly indicate malignancy and any associated findings.
Performed when the malignant neoplasm is extensive and requires removal of the uterus and surrounding structures.
Operative reports must detail the extent of the surgery and findings.
Gynecologic oncologists should ensure that all relevant findings are documented.
CA-125 is a tumor marker that may be elevated in patients with malignant neoplasms, including those affecting the round ligament. While it is not specific to this site, it can aid in monitoring disease progression and response to treatment.
